Australian Pharmaceutical Industries Ltd (API.AX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [ASX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [ASX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 08/31
| 08-2011 | 08-2010 | 08-2009 | 08-2008 | 04-2007 | |
| Cash Flows From Operating Activities | |||||
| Operating Cash Flow | $N/A | $N/A | $N/A | $N/A | $N/A |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -12,512 | -33,571 | -34,696 | -16,100 | -16,934 |
| Net Acquisitions | N/A | N/A | N/A | 12,451 | 2,051 |
| Purchase Sale Intangibles | -102 | -842 | -161 | -215 | -6,364 |
| Other Investing Activity | -1,145 | 19,686 | 182 | 6,677 | -2,256 |
| Investing Cash Flow | $-13,759 | $-14,727 | $-34,675 | $2,813 | $-23,503 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | N/A | N/A | 4,931 | 1 |
| Debt Repayment | N/A | N/A | -10,000 | -69 | N/A |
| Common Stock Issued | N/A | 145,660 | N/A | N/A | N/A |
| Dividend Paid | -12,203 | -10,028 | -2,573 | N/A | -7,720 |
| Other Financing Activity | -17,056 | -140,664 | -1,363 | -5,514 | -33,977 |
| Financing Cash Flow | $-29,259 | $-5,032 | $-13,936 | $-652 | $-41,696 |
| Exchange Rate Effect | -20 | -16 | 2 | 633 | -139 |
| Beginning Cash Position | 29,431 | 5,856 | 42,906 | 9,558 | 30,060 |
| End Cash Position | 34,605 | 29,431 | 5,856 | 42,906 | 14,622 |
| Net Cash Flow | $5,194 | $23,591 | $-37,052 | $32,715 | $-15,299 |
| Free Cash Flow | |||||
| Capital Expenditure | -18,333 | -34,493 | -43,617 | -26,557 | -25,636 |
| Free Cash Flow | -18,333 | -34,493 | -43,617 | -26,557 | -25,636 |